Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (<i>S</i>)-CE-123 on Mesocorticolimbic Dopamine System

Treatments for cognitive impairments associated with neuropsychiatric disorders, such as attention deficit hyperactivity disorder or narcolepsy, aim at modulating extracellular dopamine levels in the brain. CE-123 (5-((benzhydrylsulfinyl)methyl) thiazole) is a novel modafinil analog with improved sp...

Full description

Bibliographic Details
Main Authors: Claudia Sagheddu, Nicholas Pintori, Predrag Kalaba, Vladimir Dragačević, Gessica Piras, Jana Lubec, Nicola Simola, Maria Antonietta De Luca, Gert Lubec, Marco Pistis
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/10/5/779
_version_ 1797567717446778880
author Claudia Sagheddu
Nicholas Pintori
Predrag Kalaba
Vladimir Dragačević
Gessica Piras
Jana Lubec
Nicola Simola
Maria Antonietta De Luca
Gert Lubec
Marco Pistis
author_facet Claudia Sagheddu
Nicholas Pintori
Predrag Kalaba
Vladimir Dragačević
Gessica Piras
Jana Lubec
Nicola Simola
Maria Antonietta De Luca
Gert Lubec
Marco Pistis
author_sort Claudia Sagheddu
collection DOAJ
description Treatments for cognitive impairments associated with neuropsychiatric disorders, such as attention deficit hyperactivity disorder or narcolepsy, aim at modulating extracellular dopamine levels in the brain. CE-123 (5-((benzhydrylsulfinyl)methyl) thiazole) is a novel modafinil analog with improved specificity and efficacy for dopamine transporter inhibition that improves cognitive and motivational processes in experimental animals. We studied the neuropharmacological and behavioral effects of the <i>S</i>-enantiomer of CE-123 ((<i>S</i>)-CE-123) and <i>R</i>-modafinil in cognitive- and reward-related brain areas of adult male rats. In vivo single unit recordings in anesthetized animals showed that (<i>S</i>)-CE-123, but not <i>R</i>-modafinil, dose-dependently (1.25 to 10 mg/kg i.v.) reduced firing of pyramidal neurons in the infralimbic/prelimbic (IL/PrL) cortex. Neither compound the affected firing activity of ventral tegmental area dopamine cells. In freely moving animals, (<i>S</i>)-CE-123 (10 mg/kg i.p.) increased extracellular dopamine levels in the IL/PrL, with different patterns when compared to <i>R</i>-modafinil (10 mg/kg i.p.); in the nucleus accumbens shell, a low and transitory increase of dopamine was observed only after (<i>S</i>)-CE-123. Neither (<i>S</i>)-CE-123 nor <i>R</i>-modafinil initiated the emission of 50-kHz ultrasonic vocalizations, a behavioral marker of positive affect and drug-mediated reward. Our data support previous reports of the procognitive effects of (<i>S</i>)-CE-123, and show a minor impact on reward-related dopaminergic areas.
first_indexed 2024-03-10T19:46:27Z
format Article
id doaj.art-2bc9da98571c46c5b7965106ce4c0ddf
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T19:46:27Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-2bc9da98571c46c5b7965106ce4c0ddf2023-11-20T00:47:14ZengMDPI AGBiomolecules2218-273X2020-05-0110577910.3390/biom10050779Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (<i>S</i>)-CE-123 on Mesocorticolimbic Dopamine SystemClaudia Sagheddu0Nicholas Pintori1Predrag Kalaba2Vladimir Dragačević3Gessica Piras4Jana Lubec5Nicola Simola6Maria Antonietta De Luca7Gert Lubec8Marco Pistis9Department of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, ItalyDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, ItalyDepartment of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, 1010 Vienna, AustriaDepartment of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, 1010 Vienna, AustriaDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, ItalyDepartment of Neuroproteomics, Paracelsus Medical University, 5020 Salzburg, AustriaDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, ItalyDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, ItalyDepartment of Neuroproteomics, Paracelsus Medical University, 5020 Salzburg, AustriaDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, ItalyTreatments for cognitive impairments associated with neuropsychiatric disorders, such as attention deficit hyperactivity disorder or narcolepsy, aim at modulating extracellular dopamine levels in the brain. CE-123 (5-((benzhydrylsulfinyl)methyl) thiazole) is a novel modafinil analog with improved specificity and efficacy for dopamine transporter inhibition that improves cognitive and motivational processes in experimental animals. We studied the neuropharmacological and behavioral effects of the <i>S</i>-enantiomer of CE-123 ((<i>S</i>)-CE-123) and <i>R</i>-modafinil in cognitive- and reward-related brain areas of adult male rats. In vivo single unit recordings in anesthetized animals showed that (<i>S</i>)-CE-123, but not <i>R</i>-modafinil, dose-dependently (1.25 to 10 mg/kg i.v.) reduced firing of pyramidal neurons in the infralimbic/prelimbic (IL/PrL) cortex. Neither compound the affected firing activity of ventral tegmental area dopamine cells. In freely moving animals, (<i>S</i>)-CE-123 (10 mg/kg i.p.) increased extracellular dopamine levels in the IL/PrL, with different patterns when compared to <i>R</i>-modafinil (10 mg/kg i.p.); in the nucleus accumbens shell, a low and transitory increase of dopamine was observed only after (<i>S</i>)-CE-123. Neither (<i>S</i>)-CE-123 nor <i>R</i>-modafinil initiated the emission of 50-kHz ultrasonic vocalizations, a behavioral marker of positive affect and drug-mediated reward. Our data support previous reports of the procognitive effects of (<i>S</i>)-CE-123, and show a minor impact on reward-related dopaminergic areas.https://www.mdpi.com/2218-273X/10/5/779cognitive enhancerprefrontal cortexdopaminedopamine transportermodafinilreward
spellingShingle Claudia Sagheddu
Nicholas Pintori
Predrag Kalaba
Vladimir Dragačević
Gessica Piras
Jana Lubec
Nicola Simola
Maria Antonietta De Luca
Gert Lubec
Marco Pistis
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (<i>S</i>)-CE-123 on Mesocorticolimbic Dopamine System
Biomolecules
cognitive enhancer
prefrontal cortex
dopamine
dopamine transporter
modafinil
reward
title Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (<i>S</i>)-CE-123 on Mesocorticolimbic Dopamine System
title_full Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (<i>S</i>)-CE-123 on Mesocorticolimbic Dopamine System
title_fullStr Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (<i>S</i>)-CE-123 on Mesocorticolimbic Dopamine System
title_full_unstemmed Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (<i>S</i>)-CE-123 on Mesocorticolimbic Dopamine System
title_short Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (<i>S</i>)-CE-123 on Mesocorticolimbic Dopamine System
title_sort neurophysiological and neurochemical effects of the putative cognitive enhancer i s i ce 123 on mesocorticolimbic dopamine system
topic cognitive enhancer
prefrontal cortex
dopamine
dopamine transporter
modafinil
reward
url https://www.mdpi.com/2218-273X/10/5/779
work_keys_str_mv AT claudiasagheddu neurophysiologicalandneurochemicaleffectsoftheputativecognitiveenhancerisice123onmesocorticolimbicdopaminesystem
AT nicholaspintori neurophysiologicalandneurochemicaleffectsoftheputativecognitiveenhancerisice123onmesocorticolimbicdopaminesystem
AT predragkalaba neurophysiologicalandneurochemicaleffectsoftheputativecognitiveenhancerisice123onmesocorticolimbicdopaminesystem
AT vladimirdragacevic neurophysiologicalandneurochemicaleffectsoftheputativecognitiveenhancerisice123onmesocorticolimbicdopaminesystem
AT gessicapiras neurophysiologicalandneurochemicaleffectsoftheputativecognitiveenhancerisice123onmesocorticolimbicdopaminesystem
AT janalubec neurophysiologicalandneurochemicaleffectsoftheputativecognitiveenhancerisice123onmesocorticolimbicdopaminesystem
AT nicolasimola neurophysiologicalandneurochemicaleffectsoftheputativecognitiveenhancerisice123onmesocorticolimbicdopaminesystem
AT mariaantoniettadeluca neurophysiologicalandneurochemicaleffectsoftheputativecognitiveenhancerisice123onmesocorticolimbicdopaminesystem
AT gertlubec neurophysiologicalandneurochemicaleffectsoftheputativecognitiveenhancerisice123onmesocorticolimbicdopaminesystem
AT marcopistis neurophysiologicalandneurochemicaleffectsoftheputativecognitiveenhancerisice123onmesocorticolimbicdopaminesystem